(Boursier.com) — IQVIA , the American leader in clinical research and health data, announced for its fourth quarter revenues totaling $3.74 billion, GAAP net income of $227 million and adjusted Ebitda of $920 million. Adjusted diluted earnings per share were $2.78 for the period. The consensus was $2.76 in adjusted EPS for $3.71 billion in revenue. For the year, revenues totaled $14.41 billion, for a net profit of $1.09 billion in GAAP and an adjusted Ebitda of $3.35 billion. R&D Solutions quarterly bookings top $3.1 billion, representing a 1.51x book-to-bill ratio. The R&D solutions backlog of $27.2 billion increased 9.6% year-on-year and 11.6% excluding the impact of exchange rates.
©2023 Boursier.com